Robeco Institutional Asset Management B.V.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1418773
ROTTERDAM, P7
Position in RDY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$261,125,739
+$23,212,074 QoQ
Shares Held
18,021,100
+4.9% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1
of 58 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (64.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
This page
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
164,014 | $4,161,035 |
All Filings in RDY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,125,739 | 18,021,100 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $237,913,665 | 17,177,882 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $184,689,516 | 13,154,524 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $182,921,393 | 13,084,506 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $182,816,322 | 12,163,428 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $141,281,202 | 10,711,236 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $180,620,357 | 11,438,908 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $164,103,657 | 2,065,496 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $157,654,709 | 2,069,231 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $144,845,712 | 1,974,720 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $120,051,940 | 1,725,380 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $111,881,935 | 1,673,126 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $91,794,820 | 1,454,521 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $60,068,949 | 1,055,137 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $45,708,808 | 883,262 | Shares | Defined | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||